CN Patent

CN106692124A — 乙酰半胱氨酸药物组合物及其制备方法

Assigned to Tibet Xingkang Pharmaceutical Ltd By Share Ltd · Expires 2017-05-24 · 9y expired

What this patent protects

本发明的目的在于提供更稳定的乙酰半胱氨酸药物组合物及其制备方法。乙酰半胱氨酸药物组合物包含乙酰半胱氨酸和医学上可接受的辅料，该组合物水溶液的pH值为7.0～7.5。

USPTO Abstract

本发明的目的在于提供更稳定的乙酰半胱氨酸药物组合物及其制备方法。乙酰半胱氨酸药物组合物包含乙酰半胱氨酸和医学上可接受的辅料，该组合物水溶液的pH值为7.0～7.5。

Drugs covered by this patent

Patent Metadata

Patent number
CN106692124A
Jurisdiction
CN
Classification
—
Expires
2017-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Tibet Xingkang Pharmaceutical Ltd By Share Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.